Europe’s Beating Cancer Plan

The association representing European community pharmacists (PGEU) welcomes the main ambitions of Europe’s Beating Cancer Plan as outlined in the European Commission Roadmap. We believe that the 4 domains identified in the Roadmap are each of crucial importance and should be tackled at a European level to meaningfully complement existing national cancer plans of EU Member States.

The Societal Impact of Pain (SIP) (www.sip-platform.eu/sip-joint-statement), welcomed the European Commission Roadmap on Europe’s Beating Cancer Plan. “SIP belies that as bread features heavily in the lives of cancer patients and survivors it must be addressed in the plan. Estimateded bread prevalence in cancer patients is around 70 %; 80 % for teas with advanced traineeships.

Filed in French · English published by the European Commission

The international and multidisciplinary consortium Cancer Prevention Europe (CPE) was created in 2018 to develop world class prevention research to be translated into effective cancer prevention guidelines and policies at the national and international level. CPE is a consortium of leading European research institutions committed to prioritizing cancer prevention through cooperation between countries and programmes.

AESGP congratulates the European Commission for the focus given on Cancer and on the established roadmap. AESGP agrees that this stringent healthcare problem needs particular overarching solutions and a transversal collaboration across Member States and different levels of care. AESGP welcomes the division of the European Beating Cancer Plan into 4 main areas: prevention, early diagnosis, treatment and care.

The Association Végétarienne de France, in collaboration with the European Vegetarian Union, would like to highlight the strong relation between diets, food consumption and health concerns in the European Union. In France, people consume much more meat than recommended by WHO and by the European Food Safety Authority.

Sanofi Comments on Roadmap to Europe’s Beating Cancer Plan: The EU’s ambition of a comprehensive approach to cancer is encouraging and should contribute to further public and private resource allocation in cancer, which are necessary considering its increasing burden on health.

A Cancer Plan should take into account organisational aspects of health care at different stages of the disease as well as early and diagnostic and therapeutic/early treatment aspects. It is essential that there should be an interdisciplinary participation in the preparation of the plan and always take into account the families next to the patient in order to provide the best health care to the family unit, which is…

Filed in Spanish · English published by the European Commission

Thank you very much to the European Commission for launching the “Europe’s Beating Cancer Plan”. It is a real political opportunity to put in place the necessary measures to save more lives and also to increase the quality of life of thousands of patients.

Filed in French · English published by the European Commission

Established in 1986, EASO is a federation of professional membership associations from 34 countries, with a network of over 130 specialist Collaborating Centres for Obesity Management across the region. EASO’s mission is to reduce the burden of unhealthy weight, and it promotes action through collaboration in research, education and policy.

I am feeding back as Chair of the SIOPE Brain Tumour Group. Paediatric cancer (PC) and specifically brain tumours are the leading cause of death by disease in children older than 1 year in Europe. Many brain tumour entities have a dismal outcome and survivors often have significant life long late effects.

The roadmap “Europe’s beating cancer plan” addresses important points and notes the importance of data sharing. Information derived from data obtained on such scale can be used to improve the prevention, detection, treatment and management of cancer in the EU. Medical administrative data are more and more organized and structured at national levels, and become a major source of useful public health information.

TO: MATTHIAS SCHUPPE, PROJECT LEADER, EUROPEAN BEATING CANCER PLAN 3 MARCH 2020 Dear Mr Schuppe, This submission is from the European CanCer Organisation (ECCO), an umbrella federation of 28 European organisations of professionals related to oncology working in cancer at a European level, closely advised via 17 European patient advocacy groups.

We commend the European Commission, and the European Union, for taking on this project. We especially appreciate the objective listed in Section B to “set out actions that support, coordinate, or supplement Member States’ efforts”.

There are four significant ways in which the endocrine system relates to cancer 1. 40% of all cancers are associated with overweight and obesity: endometrial, postmenopausal breast and colorectal cancer – all related to the endocrine system – account for over 60% of all cancers attributed to obesity. 2. EDCs have an effect on different hormones and affect both the development of obesity and cancer [1]. 3.

In our opinion, the European Commission should include in the European Oncological Plan the role of alternative products to traditional tobacco products. It is mainly about electronic cigarettes and innovative tobacco products (heat not burn). Scientific research confirms that the use of alternative nicotine products helps to stop smoking traditional cigarettes.

The necessity to develop a European Cancer Plan to support national initiatives is reinforced by future challenges. With an aging population, new cases of cancer should increase by 60% during the next 20 years. Struggle against cancer requires the permanent investment of all health actors, associations, patients and authorities.

Europe´s Beating Cancer Plan – EADV  What are the challenges in your country with regard to melanoma and skin cancer? Until recently, true numbers of non-melanoma skin cancers have been significantly underestimated. In the Dutch National Cancer Registry we now have full insight in the incidence of skin cancers, which showed skin cancer to be the most common type of cancer.

Opening of the attached position paper · the full paper is on the Commission’s record (source link above)

Paediatric cancers represent the main cause of death due to disease in children over 1 in Europe — There are major inequalities in access to treatment and in survival rates. — paediatric cancers have age related specificities and require personalised approaches beyond those shared with cancer.

Filed in Spanish · English published by the European Commission

The Good Clinical Practice Alliance – Europe (GCPA) and the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) wish to thank DG Santé of the European Commission for the opportunity to respond to the proposed Roadmap for ‘Europe’s Beating Cancer Plan’.

The Clinic of Social and Family Medicine (CSFM) of the University of Crete welcomes this initiative of the European Commission to gather insights from all stakeholders for the Roadmap to Europe’s Beating Cancer Plan.

Too many people in the EU and WHO Europe region are still living with hepatitis B and C. 29 million people (15 million with HCV, 14 million with HBV) are infected across WHO European region and EU member’s state. They are at risk of liver cancer, feeling stigmatized and lonely despite the fact that elimination is feasible and can be achieved. We know for the fact that hepatitis C is a curable disease.

Combating cancer in the EU must include combating it among communities facing the greatest economic and social precarity and the greatest barriers to accessing care. This requires adopting measures ensuring that no one is deprived of preventative or curative care because of their residence status or due to social marginalisation; and that everyone is protected from toxic working environments, including undocumented…

The European Cancer Plan should include a policy to encourage the current users of tobacco products to move to e-cigarette products. Studies in Member States such as Poland and France show that alternative tobacco products are an effective way of throwing down conventional cigarettes.

Filed in Polish · English published by the European Commission

AbbVie welcomes the EU Beating Cancer Plan. As a highly focused research-driven biopharmaceutical company, AbbVie targets specific difficult-to-treat diseases in areas of high unmet need where we can leverage our core R&D expertise to advance science. Oncology is one of our main research priorities, we would like to provide constructive suggestions on how the EU can make progress in beating cancer.

The Panhellenic Association of Parents of Children with Forage Cancer welcomes the European Plan to Combat Cancer. Childhood cancer (cancer) is the 1st cause of death (from disease) to children and is different from cancer in adults in terms of causes, but also appropriate treatment and prognosis.

Filed in Greek · English published by the European Commission

The research-based pharmaceutical industry remains committed to improving cancer prevention, diagnosis, treatment and quality of life of patients. The last two decades have seen great progress in treatment innovation allowing people affected by cancer to live longer and more productive lives.

This is a very commendable initiative. As a Smoking Cessation expert, I am pleased to have the opportunity to put my views forward. I am Vice-Chair of the New Nicotine Alliance, which is an educational charity based in the UK. I was the Stop Smoking Service lead for Leicester City (England) from 2004 to 2018, and now work as a freelance consultant.

As a global specialty-driven biopharmaceutical company committed to discovering new solutions for targeted debilitating diseases and improving quality of life for patients Ipsen welcomes the opportunity to comment on the proposed roadmap for Europe’s Beating Cancer Plan.

Please find attached feedback from the Taxpayers Protection Alliance, a Washington DC based non-partisan non-government organization (NGO) representing taxpayers and consumers. We thank the European Commission for the opportunity to contribute to Europe’s Plan for beating cancer.

EUPHA, the European Public Health Association, is pleased with the opportunity for responding to the Roadmap for the Commission’s initiative: Europe’s Beating Cancer Plan. Action on cancer starts with prevention, as acknowledged in the Commission’s plan.

Roche strives to transform the lives of people with cancer and those who support them. With a large portfolio in diagnosing, treating and managing cancer, Roche can contribute to the design and implementation of Europe’s Beating Cancer Plan in two main areas: innovation in diagnostic procedures and personalized cancer treatment, and data and information management for better outcomes.

The European Molecular Biology Laboratory (EMBL) fully agrees with the statement that further basic research will play an instrumental role in better understanding risk factors and causes, as well as defining new ways to detect, prevent, and treat cancer. Recently speaking on behalf of the Cancer Mission Board during an ITRE hearing, C.

Prevention The use of “digital tools” commensurately reflects the variety of different approaches that become available. It should be emphasised that techniques to handle tumour profile data will not be limited to genomics only (see the recent perspective on “deep phenotyping” tumours: https://www.nature.com/articles/s41571-019-0273-6 ) and that a variety of digital tools, including computer modeling and simulation…

Thank you for the opportunity to present the proposals of patients and healthcare professionals involved in EURACAN, the European Reference Network (ERN) for rare adult solid cancers. Twenty percent of all new cancers per year are rare, based on the RARECARE definition (incidence <6/100,000/year) and they represent 30% of cancer mortality.

ASPNION is the Association of Parents of Children with Cancer in the Autonomous Community of Valencia, set up in 1985, by the families themselves, with the aim of ensuring the best quality of life for children and adolescents with cancer and their families through: Psychological, social and economic support, information and dissemination, prevention and social inclusion, support for research, etc., Apanion is a…

Filed in Spanish · English published by the European Commission

GE Healthcare is a leading provider of medical imaging, monitoring, digital, services, biomanufacturing and cell & gene therapy technologies. On a daily basis, a broad range of our medical equipment such as x-ray, ultrasound, mammography, MRI, low-dose CT, PET CT, molecular imaging (MI), MI diagnostic tracers & contrast media as well as our data & AI driven solutions, predictive analytics & services are utilized by…

The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) is the voice of the 200 million people living with allergy, asthma and chronic obstructive pulmonary disease (COPD) in Europe. We bring together 43 national associations from 25 countries and channel their knowledge and demands to the European institutions.

The medtech industry welcomes the EU’s Beating Cancer Plan and is committed to working with all stakeholders contributing to medical advances in the area of cancer. Medical technologies play an essential role in driving the 4 pillars of this plan. In-vitro diagnostics (IVDs) provide information on the likelihood of developing cancer at an early stage, the presence and type of cancer, and treatment success.

The European University Hospital Alliance* (EUHA) consists of nine of Europe’s leading university hospitals from nine countries. EUHA welcomes the initiative to develop Europe’s Beating Cancer Plan and the comprehensive approach from prevention to people’s life post-cancer, especially seen in connection with the Mission on Cancer in Horizon Europe.

The issue: Over 1,000 European citizens die from lung cancer each and every day, with this number set to increase considerably within the next decade. This disease has a poor five-year survival rate, which varies widely both within and across EU countries.

ESTRO (European SocieTy for Radiotherapy and Oncology) would like to thank the European Commission for the ambitious plan, providing to the oncology community shared priorities. ESTRO reiterates the importance of multidisciplinary cancer care, for a care pathway that is targeted to the patient.

FEV is the national association that represents the Spanish wine sector among the Spanish, European and international authorities. A.1. CONTEXT FEV welcomes the EC’s decision to involve non-state actors in the EU Cancer Plan and reaffirms its strong commitment to support any action aimed at reducing harmful use of alcohol and promote balance lifestyles.

The Belgian foundation KickCancer is thankful for the opportunity to give feedback on the EU Beating Cancer plan roadmap. We are however worried that the current plan does not take into account the specific needs of some of its most fragile citizens: children, adolescents and young adults.

Elekta welcomes the Roadmap on Europe’s Beating Cancer Plan, and it applauds the European Commission for taking a decision to put the fight against cancer on the top of its political agenda. Elekta, as a global leader and the only European company specialised in the production of radiation therapy technologies for cancer treatment, appreciates the fact that the Europe’s Beating Cancer Plan will deal with every step…

Although Europe represents 6% of the world population, it retains 25% of the global cancer burden. In 2019, an estimated 1.4 million of people died of cancer in the European Union, making cancer the second most common death in the EU. With the increasing number of incidences, we believe that it will become the leading cause of death in the future.

Johan CHANAL1, Marie-Noëlle CREPY1,2, Lynda BENSEFA colas2 (1) Dermatology of the Cochin-Centre for the Reference Centre for skin cancers and (2) Service for occupational diseases, Hospital Group Paris Centre, Paris, France Skin cancers are mainly represented by skin carcinoma and skin melanoma. The primary risk factor is exposure to natural UV (UVN). In France, there are no epidemiological codes for skin carcinoma.

Filed in French · English published by the European Commission

The American Chamber of Commerce to the EU (AmCham EU) welcomes the recently published Roadmap on Europe’s Beating Cancer Plan. Health is an important driver for wealth and economic growth and we support the EU agenda towards affordable, sustainable and innovative health systems.

Institut Mérieux welcomes the Roadmap on “Europe’s Beating Cancer Plan”, and its holistic and citizen/patient-centred approach. We agree on the lack of health policies and holistic interventions regarding prevention.

Baxter Healthcare welcomes the European Commission’s initiative to propose the EU Beating Cancer Action Plan. Cancer is one of the leading causes of death and contributes to 20% of the total disease burden in Europe1.

The European Public Health Alliance (EPHA) welcomes Europe’s Beating Cancer Plan as a flagship health initiative that can deliver real added value for Europeans. In response to the Road Map, EPHA highlights the following considerations: 1. The Plan should include a thorough and effective prevention pillar with special attention to tackling challenges common to all non-communicable diseases (NCDs).

The European Technology Platform on Nanomedicine (ETPN) strongly supports and endorses the proposed roadmap for Europe’s Beating Cancer Plan. It focuses on four pillars: prevention, early diagnosis, treatment & social aspects, including equal access to quality and affordable cancer care across Europe.

According to the estimates provided by the International Agency for Research on Cancer, pancreatic cancer affects 132.000 Europeans every year and kills 128.000[i]. The main challenges around pancreatic cancer are the delays in diagnosis and the high mortality. The lack of research and European registries, and poor political consideration impair the progress in the control of this cancer.

The European Cancer Plan should include a policy to encourage the current users of tobacco products to move to e-cigarette products. Research carried out in the Member States shows that alternative tobacco products are an effective way of throwing down conventional cigarettes. For example, according to research, e-cigarettes contribute to the cessation of smoking in more than 20.000 people per year.

Filed in Polish · English published by the European Commission

We consider this European Union initiative to develop a European anti-cancer plan very positively from the Nursing Union, but it is our understanding that it leaves aside the safety of health professionals handling dangerous medicines.

Filed in Spanish · English published by the European Commission

The Hungarian Alliance of Patient Organisations (BEMOSZ) is a representative, independent umbrella organisation of 10 Hungarian patient organisations: Hungarian Coeliac Society Hungarian Cancer League Hungarian Williams Syndrome Association Hungarian Stroke Prevention and Rehabilitation League Hungarian Osteoporosis Association Hungarian Federation of Rare Diseases Heart SN Society Hungarian Fabry Foundation…

Philips welcomes the intention of the European Commission to reduce the cancer burden in the EU and to address cancer-related inequalities between and within Member States. We recognize the issues identified in the Roadmap and support the proposed holistic approach towards cancer, including equal access to early diagnosis and treatments, quality of life of patients and their families, and filling the knowledge gaps.

The roadmap We welcome the European Commission’s roadmap on Europe’s Beating Cancer Plan. The roadmap takes into consideration key issues with the aim to keep reducing the incidence of cancer affirming that “There is a great potential in increased combination and sharing of available data collected from clinical experience and research.” Furthermore, the initiative aims to achieve specific goals in the domain of…

The "Transforming Breast Cancer Together" multi-stakeholder initiative welcomes the European Commission (EC) consultation on Europe’s Beating Cancer Plan and the roadmap’s holistic approach. The Plan should be ambitious and build on existing tools to support Member States’ actions on cancer. Patients and their needs should be the guiding principle of the Plan.

As an association that states with sensitivity and registration of bone Marrow donors in order to cover children, vegetables, research and psychological support, especially for children and adolescents, before, during and after treatment

Filed in Italian · English published by the European Commission

Medicinal Cannabis Europe is a patient-driven advocacy group, comprising scientific organisations, academia, patient organisations, NGOs and industry, which aims to ensure fair access for patients to high quality, safe, cannabis-derived medicine and to demonstrate the benefits of medicinal cannabis for patients towards European policymakers.

ANT Foundation welcomes the Beating Cancer Plan. ANT is an Italian no-profit Foundation that provides since 1985 free medical, nursing, psychological and social home care and support for cancer patients. ANT is the largest Italian non-profit organization and since its foundation, it has assisted more than 130.000 patients.

We wish to thank EU for the opportunity to be able to send a contribution to the discussion. We agree on the roadmap. Our scientific society SIFO, the Italian Society of Hospital Pharmacy and Pharmaceutical Services of Healthcare Companies, is currently engaged on several fronts regarding the cancer emergency: safety in places of care for patients and operators exposed to dangerous drugs including cytotoxic; safety…

I am not European, nor am I a smoker, yet I feel empathy with the smokers of Europe as I do for smokers worldwide. That is because I smoked for 29 years and it has extensively harmed my health. It is likely that, despite having quit smoking, my past history of smoking still makes me more prone to suffering from cancer. But I was fortunate in discovering vaping.

The nuclear medicine community, represented through the European Association of Nuclear Medicine (EANM) highly appreciates the Beating Cancer Plan initiative. Many key aspects outlined in the road map are embraced by EANM, this especially includes access, equality and quality of life of our patients.

From the Spanish Association Against Cancer Prevention • Children and young adults must be a priority within the BCP. Cancer burden can be significantly reduced by increasing efforts to grow up a healthy next generation. Focus on primary prevention and healthy environments.

A toxic-free environment as long-term cancer preventing environment : some chemicals in the work & home environment are known to be carcinogenic; others disrupt the human hormone system & are associated with hormonal cancers, such as breast or prostate cancer.

Central European Cooperative Oncology Group (CECOG) | Bridging the gaps in cancer care The absolute number of people diagnosed with cancer rose around 50% in Europe over the past 20 years. However, the number of deaths only increased by 20%. Allowing for population growth and ageing, in real terms cancer deaths are falling .

The Alliance welcomes the European Beating Cancer Plan. We have been campaigning for the inclusion of environmental and occupational risk factors into cancer plans for over 2 decades. Along with From Pink to Prevention campaign and the Lincolnshire Cancer Project we hope this EU plan and Code will provide a template that will be reproduced in all European cancer plans and beyond, along with a mandatory agreement to…

All.Can is a multi-stakeholder initiative aiming to improve efficiency in cancer care by focusing on what matters to patients. Over 20% of all healthcare spending is wasted on ineffective interventions; what this figure specifically represents in cancer care is not well understood. Efficiency, however, should not be confused with cost containment. It is about focusing resources on what matters to patients.

Cancer-related complications and comorbidities are a highly significant burden on patients across Europe that is all too often neglected in policy and research. The European Brain Council, as part of the Cancer Related Complications and Comorbidities Initiative (which brings together relevant stakeholders at the EU level), defines a comorbidity as the co-existence of disorders in addition to a primary disease…

The EU’s Beating Cancer Plan needs to be comprehensive and reflecting existing best practice national level cancer plans. The plan should avoid generic terms such as ‘people from all walks of live’ and be more age-specific to highlight the differences between the generations such as ‘children, adolescents, young adults, middle-aged adults and older adults’.

The European Social Insurance Platform (ESIP), representing the statutory social and health insurances in 18 EU Member States and Switzerland, welcomes the Commission’s initiative to raise the profile of health at EU level, in its Europe’s Beating Cancer Plan. There is potential for true EU added value by taking a holistic approach and tackling the challenge via a wide range of policies and instruments.

The research-based pharmaceutical industry, represented by the Romanian Association of International Medicine Producers (ARPIM), is committed to collaborate with health authorities for the elaboration of a Cancer Plan, as Romania is one of the few countries in Europe who does not have one.

The Cancer Related Complications and Comorbidities Initiative brings together relevant stakeholder on the EU level. [i] We define a comorbidity as the co-existence of disorders in addition to a primary disease (cancer) and a cancer complication as a complication resulting from the underlying malignancy or its treatment.

The EFBWW welcomes the Commission`s communication for “A strong social Europe for just transition” in the context of the Green Deal and including the Europe´s Beating Cancer Plan. The plan will not be successful without a comprehensive EU occupational health and safety strategy regarding occupational cancer. In this context, the EFBWW as a European Social Partner would like to highlight the following points: 1.

March, 2nd, 2020 Statement of the Austrian Society of Dermatology and Venereology Concerning EU‘s Roadmap on Europe’s Plan Beating Cancer The Austrian Society of Dermatology and Venereology is a national society comprising of approx. 1200 members. Dermatological oncology is one of our main topics, as skin cancer is extremely frequent and could be prevented in many instances.

Federació Catalana Entitats contra el Càncer’s response to consultation by 3 March 2020 BCP should aim to organise our society and economy to benefit EU citizens, cancer patients and survivors. The goal should be to close the inequalities gaps between and within MS, focusing on key areas where Europe should work together to improve cancer control and care.

The Vall Hebron Hospital Campus (represented by the Vall Hebron Institute of Oncology – VHIO, and the Vall Hebron Research Institute - VHIR) supports the Commission’s “Europe’s Beating Cancer Plan” and its coordination with other initiatives (Cancer Mission in Horizon Europe, European Innovation Council (EIC), Structural Funds).

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that enable us to help people defeat other serious chronic diseases, including obesity. Obesity is a key risk factor for cancer, and is associated with increased mortality from cancer.

The following comments on the EU initiative are made by the Finnish Association of Individual Surgeons: • What are the challenges in your country with regard to melanoma and skin cancer? HARD CHEESE [...] 1. With the ageing of the population, the number of new skin cancer cases is increasing every year. HARD CHEESE [...] 2.

Filed in Finnish · English published by the European Commission

As a biopharmaceutical company MSD welcomes the opportunity to provide feedback on the roadmap, and would like to enlist the European Commission’s support in 1) eliminating Hepatitis B and HPV-related cancers, 2) establishing a European stakeholder platform to improve patient access to new treatments, 3) creating a European Reference Network to address the high burden of lung cancer, and 4) issuing recommendations…

Europe's Beating Cancer Plan (BCP) should aim to organise our society and economy to benefit EU citizens, cancer patients and survivors. The goal should be to close the inequalities gaps between and within MS, focusing on key areas where Europe should work together to improve cancer control and care. BCP should complement and amplify the impact of national and regional cancer control plans.

The European Thrombosis and Haemostasis Alliance (ETHA) supports the overall objective of the Europe’s Beating Cancer Plan (EBCP): to improve cancer care in the EU while reducing health inequalities. However, the EBCP can increase its impact significantly by also addressing horizontal risk factors – such as those posed by cancer-associated thrombosis, which affects prevention, diagnosis, treatment and outcomes for…

MNI response to EU Beating Cancer Plan (3806 characters, spaces included) – short version The Medical Nutrition International industry (MNI) welcomes the European Commission’s initiative on the European Beating Cancer Plan. Cancer is one of the leading causes of mortality and contributes to 20% of the total disease burden in Europe.

The European Dairy Association (EDA) welcomes the opportunity to contribute to the Roadmap on Europe’s Beating Cancer Plan, especially its focus on prevention and the important role of healthy and balanced diets in life-style related diseases such as cancer.

The Lithuanian Society for Medical Oncology (LiSMO) welcomes the consultation on the roadmap paving the way for Europe’s Beating Cancer Plan. The LiSMO works closely with the European Society for Medical Oncology (ESMO), a scientific society representing over 25,000 members from over 160 countries.

The Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST, www.narechem.gr) in Greece welcomes the EU Beating Cancer Plan. Its comprehensive and EU-wide components provide assurance for continuity of established registration systems, minimizing threats imposed by personal identification directives for example or other challenges for member States lacking in place mechanisms and…

The Swedish Society of Oncology (Svensk Onkologisk Förening, SOF) welcomes the consultation on the roadmap paving the way for Europe’s Beating Cancer Plan. -SOF works closely with the European Society for Medical Oncology (ESMO), a scientific society representing over 25,000 members from over 160 countries.

ACIBEV welcomes the European Commission’s decision to involve non-state actors in the development of the EU Cancer Plan and wishes to reaffirm its strong commitment to support any action aimed at reducing harmful use of alcohol and promote balance lifestyles.

Bayer welcomes the Cancer Plan roadmap and concurs with its focus on the key stages of the disease. The European institutions can play a decisive role to increase care outcomes with pan-European initiatives and harmonizing deviating standards in prevention, treatment and care. It should be mentioned that approximately 73% of survival gains in cancer have been attribute to new medicines.

Serious infections remain one of the most common complications that cancer patients experience. Effective antibiotics are thus the supporting pillars of modern cancer treatment as they are used both for prevention and treatment of infections. Infections may come as a consequence of for example surgical procedures or a depressed immune system - caused by cancer itself or by cancer treatment.

AIM, the leading international association of healthcare funds and mutuals, welcomes the focus and intentions described in the European Commission’s roadmap. We call for a reallocation of healthcare budgets, so as to better finance prevention. A more efficient spending of the healthcare budget is necessary to improve prevention.

Eusoma would like to highlight the following comments on the roadmap: we would suggest to include in the prevention section the need to implement regular physical activity. With regard to treatment and care we would suggest to add in the possible objectives access to preferential multidisciplinary treatment and the use of basic quality indicators to evaluate quality of care.

RCC I SAMVERKAN delar kommissionens problembeskrivning och välkomnar initiativet med en uppdaterad europeisk cancerplan. Sveriges sex Regionala cancercentrum (RCC) utgör regionernas organisation för kunskapsstyrning på cancerområdet. RCC I SAMVERKAN är RCC:s nationella samordningsgrupp, som består av de sex RCC-cheferna samt den nationella cancersamordnaren vid Sveriges Kommuner och Regioner (SKR/SALAR).

The Spanish National Research Council (CSIC) very much appreciates the opportunity to contribute to Europe’s Beating Cancer Plan roadmap. It provides a comprehensive view on how the plan will contribute to improving the prevention, detection, treatment and management of cancer in the EU. Nevertheless, we would like to suggest some modifications to the text, attached to this contribution.

The Vegan Society Austria supports the feedback of the European Vegetarian Union (EVU) upon the present consultation, stressing the link between food and diets and health concerns in the European Union. At the Environment Committee hearing from 18 February 2020, Commissioner Kyriakides stated that the “Farm-to-Fork” strategy cannot be separated from the “Beating Cancer Plan” and that the Commission will work…

We are encouraged by the Roadmap for “Europe’s Beating Cancer Plan”, which could have a significant impact on the 3.5 million people diagnosed with cancer in the EU each year. Our ambition at AstraZeneca is to push the boundaries of science to eliminate cancer as a cause of death.

We welcome the opportunity to give input to this European Commission consultation on a roadmap for Europe’s Beating Cancer Plan and specifically comment on document [Ref. Ares (2020)693786 - 04/02/2020]. In summary, we agree with the suggestion to broaden the scope of cancer screening, we agree with objectives to further reduce prevalence of tobacco use and reduce environmental exposures and lastly we argue the…

BMS is grounded in the mission of delivering scientific breakthroughs to transform outcomes for cancer patients and has ignited an era of scientific innovation that has changed survival expectations in multiple tumor types through breakthroughs from taxane-based chemotherapy to immuno-oncology (I-O).

Sweden is one of the countries in the European Union with the lowest amount of deaths related to lung cancer. This is due to the fact that we have the lowest number of smokers in Europe – especially among men where 7 percent of the population are smokers, compared to 21 percent in the rest of the European Union.

The Union for International Cancer Control commends the comprehensive approach to cancer control and the strong focus on building an integrated approach that brings together all key stakeholders. Partnerships will be essential to a comprehensive response to cancer control, and we urge Member States to recognise the diverse and valuable work that civil society organisations are undertaking and integrate them within…

Rare Cancers Europe (RCE) welcomes EU efforts to build Europe’s Beating Cancer Plan to support Member States (MS), European institutions, and all stakeholders in the fight against cancer. -Neglected areas: 1) Rare cancers: 20% of all cancers are rare, including all paediatric cancers.

The Council of European Dentists (CED) welcomes the Roadmap on Europe’s Beating Cancer Plan as a timely and much-needed initiative. CED believes that prevention is better than cure, and therefore is of the opinion that the plan is heading in the right direction by shifting the focus from a curative to a preventive approach and integrating healthy living issues.

As a family organisation, we welcome the EU beating Plan and recognise it as an opportunity to improve the treatment of children with cancer, as child cancer continues to cause the number one cause of death caused by illness in children in Europe.

Filed in Bulgarian · English published by the European Commission

Johnson & Johnson, with its 3 segments – pharmaceuticals, medical devices, and consumer goods – is the largest broadly-based healthcare company in the world. We are committed to transforming cancer care in the EU by working with stakeholders on prevention, diagnosis, treatment and quality of life of those affected by the disease.

SIOPE welcomes Europe’s Beating Cancer Plan and its links with research, global agenda, and prior EU projects. -Neglected area: PAEDIATRIC CANCERS should not be overlooked: all individually rare, they are jointly the leading cause of death by disease in children older than 1 year in Europe, contribute to up to 60% life-long morbidity in survivors, and are marked by inequalities.

Vaccines Europe, representing major innovative research-based vaccine companies as well as small and medium sized enterprises operating in Europe, welcomes the draft Europe Beating’s Cancer Roadmap which acknowledges the critical role vaccination can play in cancer prevention relative to hepatitis B and human papillomavirus (HPV).

PanCare (www.pancare.eu) welcomes the EU Beating Cancer Plan and its potential to drive life-enhancing change for survivors of childhood and adolescent cancer. One of the four pillars of the EU Beating Cancer Plan is follow-up care.

EuroHealthNet welcomes the European Commission’s prioritisation of, and plans to implement, Europe’s Beating Cancer Plan. To be successful, however, ambitious commitment must be to urgently address the large scale of social and economic inequalities in cancer-related health outcomes and in population-wide opportunities for prevention.

Tobacco consume is one of the single-most causes of preventable cancer. The current estimate for Germany is 120,000 tobacco-related deaths per year (DHS Jahrbuch 2019). We are at a crossroad in the tobacco control policy. Either, we are continuing the “quit or die”-approach or we are focusing on harm reduction. For me as scientist, there is no question: I strongly recommend the harm reduction approach.

spiritsEUROPE is the trade association representing the European spirits sector. We commend the initiative of the Europe Beating Cancer plan – we are heartened to see an inclusive, multi-stakeholder, whole-of-society approach as required for this multi-factorial disease. Our sector is committed to work with this plan to find solutions and reduce alcohol-related harm.

ACCELERATE is an international multi-stakeholder platform where academic physicians and researchers, parents and patients advocates, representatives from industry and regulatory networks (EMA, FDA, PMDA, Health Canada) work together to improve and accelerate the development of innovative anticancer medicines for children and adolescents with cancer. Each year, 6000 children and young people die of cancer in Europe.

We want to thank de European Commission for the opportunity to respond to the Europe’s Beating Cancer Plan. As Leiden University Medical Center, as participant at the ‘Lets strive for more’ meeting in Brussels the 4th of February 2020, we strive to provide the best sustainable healthcare and work on health of both patients and citizens.

Cell and gene therapies are among the more promising innovations to treat cancer. Chimeric Antigen Receptor T-Cell (“CAR T” or “CAR T-cell”) treatments involve a combination of procedures that take place both in and outside of the body. Blood is taken from a patient, and T cells (a type of immune cell) are isolated and then modified, typically using a virus.

The Romanian Medical Association (RMA), through the Dermatology Research Unit of Colentina Clinical Hospital, greatly appreciates and supports the EU Commissioner of Health and Food Safety on launching Europe’s Beating Cancer Plan and would like to address several key points of managing skin cancer in Romania.

The European Commission should look at the experience of the UK in fighting tobacco addiction. The proportion of those dependent on combustible cigarettes has been lowered to one of the lowest in the EU (EU presence in the EU).

Filed in Polish · English published by the European Commission

Harm-reduction must be part of the Europe beating cancer plan In Europe, the main cause of preventable cancer remains smoking. Risk reduction is an approach that has proven effective in several areas. With regard to smoking, the Swedish example of the local nicotine product Snus, which has a reduced risk as recognized by the US FDA, demonstrates its effectiveness in reducing the harms and in particular the cancers…

The ideas of this feedback stem from the work being carried out within the H2020 project PERSIST (https://cordis.europa.eu/project/id/875406) coordinated by our entity and focused on improving the care of cancer survivors.

The LATVIAN ASSOCIATION OF MEDICAL ONCOLOGISTS (LAMO) welcomes the consultation on the roadmap paving the way for Europe’s Beating Cancer Plan. The LATVIAN ASSOCIATION OF MEDICAL ONCOLOGISTS works closely with the European Society for Medical Oncology (ESMO), a scientific society representing over 25,000 members from over 160 countries.

The Irish Cancer Society welcomes the objectives and instruments set out in the roadmap for the Europe Beating Cancer Plan (BCP) and supports the guiding principles and proposals set out in the European Cancer Leagues’ (ECL) position paper on the plan. The Irish Cancer Society welcomes the shift beyond focusing solely on treatment.

I am a scientist, trained in neuroscience, specialised in addiction. I am also a French smoking cessation specialist. Since 2009, I am following the e-cigarette development. As a smoking cessation specialist I can witness that it is a revolution. Smokers quit smoking much more easily than with Nicotine Replacement Therapy (NRT).

The EU Cancer Plan should consider the inclusion of ENDS (commonly referred to as electronic cigarettes) in its cancer reduction plan. The use of these products drastically reduces the levels of cancer biomarkers compared to conventional tobacco products. An example is the results of clinical trials carried out by the American Association for Cancer Research and the American Society of Clinical Oncology.

Filed in Polish · English published by the European Commission

Alternative tobacco products support prevention of cancer. • Shahab, L., et al. (2017). “Nicotine, carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A cross-border Study. "Ann. Intern. MED 166 (6): 390-400. • TL, et al. ‘have compounders met themir question? TOB Control 2016, 0: 1-6. 10.1136/tobaccocontrol-2016-05304 • Hecht, S., et al. (2015).

Filed in Polish · English published by the European Commission

Eindhoven University of Technology (TU/e) welcomes the roadmap’s overall objectives to improve the prevention, detection, treatment and management of cancer. To achieve these objectives the roadmap rightfully prioritises the use and uptake of digital tools to tackle cancer. By doing so the roadmap underlines the need for investing in innovative tools in all its objectives.

The New Nicotine Alliance Ireland welcomes this opportunity to comment. We would like to emphasise the importance of harm reduction in the area of tobacco control. Tobacco use is the largest preventable cause of cancers and the effort to reduce its prevalence can only be considered a positive contribution towards reducing incidence of cancer.

The Swedish Childhood Cancer Fund (NGO) welcomes the consultation of the roadmap for Europe’s Beating Cancer Plan with great humility. Being a representative of pediatric cancer, we are with confidence looking forward to a cancer plan where pediatric cancer naturally takes place on the agenda.

March, 2nd, 2020 Statement of the Austrian Society of Dermatology and Venereology Concerning EU‘s Roadmap on Europe’s Plan Beating Cancer The Austrian Society of Dermatology and Venereology is a national society comprising of approx. 1200 members. Dermatological oncology is one of our main topics, as skin cancer is extremely frequent and could be prevented in many instances.

What is missing in the field of research and should therefore be promoted by policy makers is cross-reference, inter-educational and inter-professional cooperation between the many different researchers and research institutions.

Filed in German · English published by the European Commission

Health Action International (HAI) welcomes the attention brought by the European Commission to Cancer, a disease exacting a heavy burden on patients and heavy price on societies across Europe and beyond. We appreciate this initiative’s holistic approach that focuses on prevention and treatment, with patients and caregivers at its centre, while acknowledging the grave challenges in front of us that range from…

The Portuguese Industry Association of Infant Food and Enteral & Parenteral Nutrition (ANID) as part of the Medical Nutrition International industry (MNI) welcomes the European Commission’s initiative on the European Beating Cancer Plan. Cancer is one of the leading causes of mortality and contributes to 20% of the total disease burden in Europe.

Europe contains 9% of the world population but has a 25% share of the global cancer burden. Surely the case for prevention as treatment – as well as treatment as prevention – is now here, if it wasn’t already. In the latter case, a recent study showed that halting the spread of the HIV epidemic through early treatment has been highly successful.

DGHO Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie - German Society for Hematology and Medical Oncology Response to the Beating Cancer Plan Consultation: Attachment DGHO is the German scientific medical society for hematology and medical oncology. It’s a very active medical society with >3.500 members.

The association Imagine for Margo — children without cancer- welcomed the European Commission’s initiative for the development of a European cancer plan. However, we are alert to the Commission that the cancer of children and adolescents, however, is almost not taken into account in the 1st cause of death of children by disease in Europe.

Filed in French · English published by the European Commission

IOGT-NTO is the largest temperance organisation in Sweden. It is also one of the country’s oldest NGOs with a long tradition of cultural, social and educational efforts in local communities. IOGT-NTO has extensive experience of working on alcohol policy questions, which includes awareness-raising about the connection between alcohol and fatal cancers.

The European Society of Radiology welcomes the roadmap on the ‘Europe’s Beating Cancer Plan’ that has identified areas of action tackling all stages of the disease. The European Commission’s openness to stakeholder input is very reflective of the disease’s complex nature which can be addressed solely by multistakeholder collaboration and a holistic approach that goes beyond the healthcare field.

AGAL welcomes and assists patients on paediatric ages and is active to contribute to the improvement of care provision and treatment practices, to increase and facilitate scientific research on paediatric diseases and to raise awareness among competent bodies directly and indirectly on these diseases. Our comments.

Filed in Italian · English published by the European Commission

Europa Donna is Europe’s breast cancer advocacy organisation with member groups in 47 countries including the 27 countries in the EU. We welcome the Beating Cancer Plan and agree with its objective of improving cancer management for all EU citizens. The Commission’s ECIBC is an essential breast cancer initiative and the Plan should ensure its timely completion and work towards its implementation in all EU countries.

The Beating Cancer Plan aims to ‘improve the prevention, detection, treatment and management of cancer.’ We would like to ensure that a broad definition of ‘treatment’ is taken and considers all approaches to cancer treatment. In particular, we wish to draw attention to approaches using radioactivity - such as radioligand therapy (also known as radionuclide therapy or molecular radiotherapy).

Europe’s Beating Cancer Plan in a great initiative. When we were at the last SIOP meeting in Lyon, last october, we here happy to find out there were some Children Cancer related Professionals on the Mission Board in the team which is extremely important. But we can't hide that we are a bit concerned that children won't be getting the attention it needs.

Endorsing — the Association of Parents and Friends of Children with Cancer, supports in Portugal 25 years ago, children and young people with cancer, and believes that it is crucial that the European oncological plan includes paediatric oncology autonomously and with specific measures.

Filed in Portuguese · English published by the European Commission

Pfizer welcomes the European Commission’s efforts laid out in the Roadmap to address the heavy burden that cancer places on people and their societies. Pfizer is committed to continuing the development of innovative methods for the prevention, diagnosis, and treatment of cancer, including cancers that become resistant to certain types of treatment.

Ladies and Gentlemen, We propose that the European Commission take into account, in its strategy, alternative tobacco products (e-cigarettes, innovative products, hearing moderation) as a tool to stop the smoking of traditional cigarettes, which are much less harmful. Many studies indicate that alternative tobacco products can help to effectively quit conventional cigarettes.

Filed in Polish · English published by the European Commission

With need 4 million people protected and a turnover of EUR 2 trillion refinanced, MGEN Group is a major player in the social welfare field and the leading insurance company in the French civil service. MGEN promotes better access to healthcare through a wide range of health and medical services accessible to all, located all over the country.

Filed in French · English published by the European Commission

The Cobalt Institute (CI) welcomes this opportunity to provide input on the European Commission’s roadmap for “Europe’s Beating Cancer Plan”. The CI represents producers, users, recyclers, and traders of cobalt globally.

Prevention Need for 1) specification environmental risk “in particular air pollution, radiation, pesticides and chemicals”, 2) Extra objective: Increase knowledge cancer risk factors because large part of cancer burden remains unexplained.

The PETA International Science Consortium Ltd. welcomes the opportunity to comment on Europe’s Beating Cancer Plan Roadmap and we strongly support initiatives to work across scientific disciplines, regulatory, and policy frameworks, as described.

Europe’s Beating Cancer Plan COCIR contribution to the EC Roadmap COCIR –the European Trade Association representing the leading industries in the medical imaging, radiotherapy, electromedical & health ICT sectors– welcomes this European Commission (EC) initiative of a cross-disciplinary Action Plan to effectively address cancer related challenges in Europe.

Since 1998, the Health Federation has been helping researchers to combat childhood cancer with the unwavering commitment of its members, its board of directors, regional directors, clubs and services, associations, volunteers and generous donors. The FENFANTS-CANECERS-SANTE is recognised as the first non-governmental source of research funding for paediatric cancer research in France. All managers are volunteers.

Filed in French · English published by the European Commission

The Civio Foundation is a non-profit organisation based in Madrid (Spain) conducting journalistic research through technology, data journalism and investigative journalism. Our mission is to monitor public authorities, inform all citizens and press for real and effective transparency in the institutions.

Filed in Spanish · English published by the European Commission

The European Policy Information Center (Epicenter) has asked me to provide some feedback to this consultation. My remarks relate to three areas of prevention. Smoking In 2019, the EU country with the lowest smoking rate was Sweden. The country with the second lowest smoking rate was the UK. Sweden and the UK have achieved this thanks to widespread consumption of snus and e-cigarettes, respectively.

The Smoke Free Partnership (SFP) is a coalition of 48 national, pan-European and global public health organisations. SFP works in collaboration with other European and global health organisations and tobacco control networks to promote the effective implementation of the WHO Framework Convention on Tobacco Control (WHO FCTC) at national, European and global level, including by promoting tobacco control information…

Cancer-related pain is a public health priority •Pain is the most common symptom of cancer at diagnosis and rises in prevalence throughout and beyond treatment. •In cancer survivors (where curative treatment was completed), between 33% and 40% suffer from chronic pain, often neuropathic nature. •In advanced cancer (incurable), 1.9 million European cancer patients die from their disease each year.

Paediatric cancers have age related specificities and require personalised approaches beyond those shared with cancer in adults, therefore extrapolation of adult services is not sufficient. The EU Cancer Plan should explicitly recognise that children and adolescents are not young adults and allocate specific recommendations for caring for them, based, for example, on the recommendations of JARC (Joint Action on RDs)…

Filed in Spanish · English published by the European Commission

The early detection and diagnosis of colorectal cancer is reliant on the provision of high-quality screening programs and access to colonoscopy services. For this reason, it is admirable that one of the key objectives of the Beating Cancer Plan is to improve the detection of cancer in the European Union (EU) with specific mention of increasing the coverage of the target population for colorectal cancer.

The Portuguese Industry Association of Infant Food and Enteral & Parenteral Nutrition (ANID) as part of the Medical Nutrition International industry (MNI) welcomes the European Commission’s initiative on the European Beating Cancer Plan. Cancer is one of the leading causes of mortality and contributes to 20% of the total disease burden in Europe.

— Alternative tobacco products are an effective way to quit conventional cigarettes A. Examples of UK campaign (70 000 smokers quit) and France b. effectiveness greater than that of the NRT or the non-use of any enabling tools.

Filed in Polish · English published by the European Commission

The Beating Cancer Plan rightly places considerable emphasis on the role of prevention and early diagnosis as the most effective ways of reducing the burden of cancer on our societies. The purpose of this submission is to request that emerging possibilities (due to new technologies and innovative approaches) of early detection be given due consideration in both the Plan and the Cancer Mission’s research efforts.

CEEV represents the wine and aromatized wine companies in the industry and trade in the EU. It gathers 23 national organisations. Its members produce and market the great majority of quality EU wines and account for over 90% of European wine exports. A.1.

As the largest specialised hospital for oncology in Bulgaria, we would like to take the work of the Roadmap. Prevention and early diagnosis are the most effective ways of combating cancer, which justifies a special focus on prevention and early diagnosis.

Filed in Bulgarian · English published by the European Commission

CHANGING THE CONTEXT FOR DIGESTIVE CANCER PATIENTS IN EUROPE Context In Europe, more than 800,000 citizens are diagnosed with digestive cancers every year (oesophagus, stomach, colon, rectum, pancreas and rare digestive cancers), and around 500,000 of them die, despite the fact that many of these deaths are avoidable: preventable and amenable.

We call on the Commission to ensure that the public interest is the driving force of the Cancer Plan and that the actions identified will be people-centered. As a coalition focused on access to medicines and public needs-driven R&I, our feedback is addressing only to the treatment pillar of the plan and the need to deliver suitable, safe, effective and affordable innovative health technologies.

The European Commission has made very clear commitments through the Sustainable Development Goals to “leave no one behind” and to ensure that all policies ensure equality mainstreaming. Commission President von der Leyen in her “Agenda for Europe” clearly recalls the commitment to the SDGs and to a Union of Equality.

UECBV welcomes the efforts of the European Commission in supporting, coordinating and complementing Member States' efforts in terms of beating cancer in the EU. In order to make more clarity and to address correctly our contribution, UECBV prefers to keep separate environmental/sustainability aspects related to environmental burden of the EU diets.

— Enhancing early childhood cancer detection measures: This aspect promotes the prevention of advanced stages of the pathology, minimises the associated costs (economic, social, etc.) associated with families, and makes cancer treatments less intrusive; Furthermore, the survival indicators should be increased. — Wear cancer monitoring: Definition of specific protocols in this respect (medium and long term).

Filed in Spanish · English published by the European Commission

We welcome the fact that the EU is working on cancer, with the launch of this plan and with the establishment of Mission Cancer under the Horizon Europe programme. We broadly share the objectives and measures outlined in the Roadmap and truly believe that EU action can make a difference.

Filed in Italian · English published by the European Commission

A. Examples of UK campaign (70 000 smokers quit) and France b. effectiveness greater than that of the NRT or the non-use of any enabling tools. Research: • Trial: Hajek et al (2019), “A randomised unit of E-Cigarettes versus Nicotine-Replacement Therapy” NEEM, at: Https://www.nejm.org/doi/10.1056/NEJMoa1808779 • UK: Beard, E., West, R., MICHIE, S., Brown, J.

Filed in Polish · English published by the European Commission

United European Gastroenterology (UEG) is a professional non-profit organisation combining all the leading European medical specialists and national societies focusing on digestive health. Together, we act as the united and trusted voice of European Gastroenterology, promoting science, research, education, quality of care and reduced health inequalities.

Eurocarers welcomes the new Commission’s ambition to beat cancer. We acknowledge the recognition in the roadmap of the impact of cancer on patients’ ‘families’ and the mention of the need to involve informal carers in a ‘holistic approach in the training’, and to address ‘the specific situation of carers’.

The European Association of Hospital Pharmacists (EAHP) welcomes the roadmap for Europe’s Beating Cancer Plan and the goals and objectives outlined within it. Tackling cancer is an important goal to achieve better health and wellbeing in Europe and EAHP appreciates the opportunity to give feedback on the roadmap.

The Portuguese Industry Association of Infant Food and Enteral & Parenteral Nutrition (ANID) as part of the Medical Nutrition International industry (MNI) welcomes the European Commission’s initiative on the European Beating Cancer Plan. Cancer is one of the leading causes of mortality and contributes to 20% of the total disease burden in Europe.

Rotterdamseweg 366 2629 HG Delft https://www.esigbond.nl/ Submission by the Dutch Esigbond regarding ‘Europe’s beating Cancer Plan’ Further reducing cancer risks: adult smokers must be encouraged to switch to vaping The Esigbond is the Dutch based trade organisation representing the interests of the mainly small distributors and retailers of e-cigarettes.

Opening of the attached position paper · the full paper is on the Commission’s record (source link above)

The Portuguese Industry Association of Infant Food and Enteral & Parenteral Nutrition (ANID) as part of the Medical Nutrition International industry (MNI) welcomes the European Commission’s initiative on the European Beating Cancer Plan. Cancer is one of the leading causes of mortality and contributes to 20% of the total disease burden in Europe.

EUROPE’S BEATING CANCER PLAN ROADMAP response of the Cancer society of Finland BCP should aim to eliminate preventable cancers, as well as to ensuring equitable early access to diagnosis and proper treatment and care, including affordable cost-effective medicines.

Very interesting and important initiative for the younger generation. We are pleased to comment on a very topical issue here: Quit smoking: The plan should pay more attention to young people in policies that encourage the consumption of E-cigarettes. Scientific evidence shows that consumption of these products helps smokers to stop smoking.

Filed in Italian · English published by the European Commission

The German Hospital Federation (GHF) welcomes the initiative of the DG SANTE, to present an action plan with measures to confront cancer, one of the leading causes of death in the EU. The GHF welcomes the method of approaching this challenge in a holistic manner by focusing not only on prevention, early detection and diagnoses, treatment and care, but also on quality of life for cancer patients, survivors, and…

The Medical Nutrition International industry (MNI) welcomes the European Commission’s initiative on the European Beating Cancer Plan. Cancer is one of the leading causes of mortality and contributes to 20% of the total disease burden in Europe.

We have read the text in question carefully, we believe that there is little attention to all of the part of the paediatric cancer that is very present and even heavy. Medicines are not developed for people of paediatric age; In-depth studies are needed in this regard and formulations that are specific to avoid a number of side effects due to the lack of harmonisation of the medicine by weight and age of the…

Filed in Italian · English published by the European Commission

The European Association of Urology fully supports the European Commission’s roadmap on the Europe’s Beating Cancer. We believe that prevention and early detection are the most effective ways of impacting this condition and fully support the potential objective of broadening the scope of cancer screening to include prostate cancer.

Health Care Without Harm Europe welcomes and supports the Europe's Beating Cancer Plan and would like to provide feedback to ensure that the prevention pillar will address common risk factors in a strategic and comprehensive way.

Urban non-profit company “CARCHINA Cancer — Information on Cancer in Childhood and adolescence” welcomes the “Being Cancer Plan” initiative and the new road opened in the fight against cancer. However, we observed that there is little reference to cancer of childhood and adolescence (12.000 children will be diagnosed with cancer in Europe only this year) and paediatric cancer (surfing), which touches 500.000 today…

Filed in Greek · English published by the European Commission

The European Commission launched the consultation on the Roadmap for an Action Plan against Cancer on 4.2.2020. The German social security fund welcomes the fact that the European Union (EU) intends to combat cancer in a holistic manner through a new action plan. The Health-in-All-Policies approach aims to involve schools, the working environment, the environment, the agri-food industry, science and research.

Filed in German · English published by the European Commission

Nutricia response to EU Beating Cancer Plan (3752 characters, spaces included) Nutricia welcomes the European Commission’s initiative on the European Beating Cancer Plan. Cancer is one of the leading causes of mortality and contributes to 20% of the total disease burden in Europe.

The National Union of Associations of Parents of Cancer Children (UNAPICLE, France) welcomes the initiative of the European Commission to draw up the EuropeanBeating Cancer Plan roadmap. In response to its request for consultation, we would like to make the following comments and proposals: — there have been 3 successive cancer plans in France.

Filed in French · English published by the European Commission

Specialised Nutrition Europe (SNE) welcomes the European Commission’s initiative on the European Beating Cancer Plan. Cancer is one of the leading causes of mortality and contributes to 20% of the total disease burden in Europe.

DIGITALEUROPE calls on European governments to accelerate the adoption and usage of data-driven Artificial Intelligence (AI). The technology is key to improve cancer care by supporting European healthcare delivery systems and research communities. In medical imaging, AI brings efficiencies by freeing up time for specialists while, at the same time, helping to maintain high-quality care over time.

Submission for public consultation on the European Commission’s Roadmap for the Europe’s Beating Cancer Plan We welcome the European Commission’s initiated work on Europe’s Beating Cancer. We believe that the Roadmap lacks proper focus on childhood cancer to address the specific needs of children and adolescents with cancer.

Opening of the attached position paper · the full paper is on the Commission’s record (source link above)

The European Commission launched the consultation on the Roadmap for an Action Plan against Cancer on 4.2.2020. The German social security system welcomes the fact that the European Union (EU) intends to combat cancer in a holistic manner through a new action plan. The Health-in-All-Policies approach aims to involve schools, the working environment, the environment, the agri-food industry, science and research.

Filed in German · English published by the European Commission

The Children’s Tumor Foundation (CTF) Europe welcomes the European Commission’s Roadmap, which outlines the high-level objectives of the forthcoming Europe’s Beating Cancer Plan. CTF Europe also welcomes the political drive with which the European Commission leadership is advancing the efforts in such a far-reaching disease. CTF Europe is a Belgian foundation concerned with neurofibromatosis (NF).

In order to combat cancer, there is a need for an interconnected system of various health agents working together with health authorities and providers, working on policies to prevent, treat and mitigate cancer.

Filed in Spanish · English published by the European Commission

The goal of BCP should be to help EU MS to take actions to reduce premature mortality from cancer, in line with the UN SDG targets and the WHO targets on non-communicable diseases by reducing mortality from cancer by 25%, to close the inequalities gaps between and within MS, focusing on key areas where Europe should work together to improve cancer control and care.

We welcome the EU Beating Cancer plan emphasizing the holistic, inclusive and patient-centred approach. We underline specific aspects in the chain of prevention to palliation, survivorship and social care. 1. As presented in the AURORA universities network statements on cancer (2019) we stress that the approach entails organizing health and care from a patient’s perspective.

We welcome the EU Beating Cancer plan emphasizing the holistic, inclusive and patient-centred approach. We underline specific aspects in the chain of prevention to palliation, survivorship and social care. 1. As presented in the AURORA universities network statements on cancer (2019) we stress that the approach entails organizing health and care from a patient’s perspective.

Erasmus University Medical Center (Erasmus MC), Rotterdam, the Netherlands congratulates the European Commission on its initiative to launch the Europe’s Beating Cancer Plan. As a large scale University Medical Centre, with a dedicated Cancer Institute, Erasmus MC applauds the EU’s initiative to fight cancer and fully supports the EU’s commitment to reduce cancer mortality by 25% in 2025.

Developing the provision of outpatient care and the city-to-hospital link The city of Montreuil supports the cancer plan of the European Commission, wishes to share its observations (at local level) and submit its proposals.

Filed in French · English published by the European Commission

SIOPE and the BSPHO welcome the EU Beating Cancer Plan and its potential to drive life-enhancing change for children and adolescents with cancer. We commend the links with research, global agenda, and prior EU projects.

The Slovak Oncology Society welcomes the consultation on the roadmap paving the way for Europe’s Beating Cancer Plan. The Slovak Oncology Society (SOS) works closely with the European Society for Medical Oncology (ESMO), a scientific society representing over 25,000 members from over 160 countries.

As a member of the European Paediatric and Adolescent Cancer Community, I call for the following items: 1. ACCESS TO ANTI-CANCER MEDICINES AND INNOVATION FOR CHILDREN AND ADOLESCENTS  Faster and more efficient development of innovative medicines for children with cancer - including in relation to the EU Paediatric Regulation: based on European Parliament Resolution on Paediatric Medicines, Dec.

First of all, Lithuanian Tobacco and Alcohol Control Coalition (hereinafter referred to as NTAKK) would like to support the European Commission’s remarks regarding too little resources being allocated for prevention efforts. As stated in the document, avoiding known risks and adopting healthy lifestyles can greatly lower people’s risk of getting cancer.

I am Milen Minkov, Past-President of the Histiocyte Society and current President of the European Consortium for Histiocytosis (ECHO). On behalf of our professional groups, which are dedicated to finding a rational cure for the histiocytoses (rare malignant diseases in children and also in adults) and to improve patient outcomes.

Smoking is one of the main causes of cancer. Many types of lung cancer are caused by smoking. In many countries vaping has been clearly associated with decreases in smoking prevalence. In UK, vaping is included in its annual “stop smoking”-campaigns. In UK thousands of ex smokers are no longer smoking due to the use of e-cigarettes.

Fiagop carries out advocacy activities in the field of paediatric oncology. First of all, I welcome this initiative, which every EU citizen cannot see with approval. Now, our comments. Reading the Roadmap, the word ‘children’ is referred to only three times; There is no direct reference to paediatric cancer.

Filed in Italian · English published by the European Commission

Detection, prevention and research of occupational and environmental cancers: the action of occupational physicians and – hygienists and the need for an institutionalized expert group at EU level Francesca Larese Filon (1), Riitta Sauni (2), Nicole Palmen (3) and Lode Godderis (4) on behalf of MODERNET gnetwork https://www.modernet.info/ (1)University of Trieste, Italy; (2) Tampere University, Finland; National…

Paediatric cancers are rare cancers. However, they often require specific approaches and special considerations about paediatric cancers are very crucial and need specific approaches by the EC, cancer community in Europe and national health systems in all member states.Today, paediatric cancers are still the leading cause of deaths in children above one year of age in Europe.

META-Health International contributes to this exciting initiative. We want to add or emphasize following points to the roadmap: Prevention: • Raising awareness for psychosomatic priming and factors contributing to cancer development • Assessment of predisposition for general or specific cancer development based on priming of lifestyle and sensitivity for specific stressors • General and individual strategies for…

The French Mutualité (FNMF) welcomes the European Beating Cancer Plan’s roadmap and wishes to share the comments and proposals below. 1) through a regional policy, with substantial funding from the cohesion and regional development funds, the EU can play a crucial role in improving access to the health of citizens, especially the most vulnerable populations for socio-economic and geographical reasons.

Filed in French · English published by the European Commission

EFFAT's response to the European Commission's consultation on the roadmap for Europe's cancer control plan The European Federation of Food, Agriculture and Tourism Trade Unions (EFFAT) welcomes the introduction of a "Plan to combat cancer in Europe" announced in the European Commission's work programme for 2020.

The European Cancer Patient Coalition (ECPC) represents the patients of its 450 members across 46 different countries afflicted by all types of cancer. [i,ii,iii] ECPC welcomes an approach that is inclusive of the entire cancer care pathway and recommends prioritizing the following actions in each respective domain: Primary prevention as the most cost-effective measure: - Set standards and explore incentives to…

The European Hospital and Healthcare Federation (HOPE) would like to make first a few precise remarks on the text of the Roadmap and then more general comments. On Chapter A, title 2 (Problem the initiative aims to tackle), sub-title 2 (Knowledge…): the risk factors are usually multiple and intricated.

Tackling infectious diseases to prevent cancer effectively Europe’s Beating Cancer Plan must become more ambitious in its objectives to improve liver cancer prevention (Roadmap section on Prevention, page 4). This means, the plan should not only work towards an improved vaccination coverage for viral hepatitis B and instead, also work towards (a) better awareness of and protection from transmission for hepatitis B…

Given Eurocare’s profile, comments are given to areas in which it possesses expertise, mainly the prevention pillar. Furthermore, comments are given in relation to EU’s level of action. European Commission is best positioned to suggest the adequate level of implementation taking into account subsidiarity and proportionality.

ORGANISATION OF THE EUROPEAN CANCER INSTITUTES www.oeci.eu Response to the European Beating Cancer Plan The Roadmap is ambitious. We suggest to use the term Primary Prevention instead of Prevention. The document should include something more about variability within and between countries, in terms of structure (what we use), process (what we do) and outcomes (what we obtain in terms of health).

The VdeH welcomes the initiative laid out in the EU Cancer Plan to tackle the causes linked to this disease. We think, though, that the outlined measures in the EU Cancer Plan are too shortsighted in respect to tobacco consumption. The only mentioned measure to decrease the smoking prevalence is higher consumer taxes.

This plan needs to include attention to children, teenagers and young adults who are going or have gone trough a cancer diagnosis. Through my charity I have got the honour of knowing many of them and I've seen the impact a childhood cancer diagnosis has on them and on their families.

The EFN welcomes the European Commission’s “Europe’s Beating Cancer Plan”, particularity on the key stages of the disease to which the focus is given, namely prevention; early diagnosis; treatment and care; and the quality of life of patients.

HIV Outcomes seeks to improve the long-term health outcomes and quality of life of all people living with HIV across Europe. It aims to identify and disseminate best practices not only among HIV specialists, but also to contribute to wider debates about the management of complex conditions such as cancer.

The Anticancer Fund supports the objective of increasing survival rates and improving quality of life of cancer patients by providing access to the best possible treatments for all. However, studies have shown that the current European system for clinical research, approval and market access of new cancer medicines is failing to achieve this goal.

The German Cancer Research Center (DKFZ) supports the Commission’s ambitious Cancer Plan to fight the growing burden of cancer in our society. Its success requires integrating all available resources and coordinating “Europe’s Beating Cancer Plan” with other initiatives (Cancer Mission in Horizon Europe, European Innovation Council (EIC), Structural Funds).

First, the European Commission should be congratulated on the Beating Cancer Plan, there is no doubt an action plan is much needed. Even more important, the specific needs to focus on rare and small cancers; such as Ovarian Cancer, have today a greater need than ever before.

Christian Carrie centre Leon berard : groupe Français de radiotherapie pediatrique : GFRP 900 children have a radiation therapy each year in France . The modalities of treatment are more en more sophisticated , time and cost consuming ; general anesthesia become more often used due to young age and accuracy of treatment .The quality assurance in paediatric radition therapy is of major concern for each prospective…

Currently, more than 80% of children treated for cancer are survivors. There is clearly a lack of structure dedicated to this population, due to a lack of means. However, as PanCare members say : It's not over when it's over. Apart from the well-known medical problems, these former patients present psychological, social and school problems, which are insufficiently cared for.

I would like to make sure that paediatric haemato-oncology is not overlooked in the EU agenda - in particular since out of the current roadmap’s 2300 words, “children” is cited only 3 times, mostly without stating the intention to focus on their specific problems, and the word “paediatric” only once.

ETUC response to the consultation of the European Commission on the roadmap of the plan "Europe's Beating Cancer" The European Trade Union Confederation (ETUC) welcomes the announcement in the European Commission Work Programme for 2020 for a "Europe’s Beating Cancer Plan".

BEUC welcomes the Commission’s commitment to improve the prevention, detection, treatment and management of cancer in the EU while reducing health inequalities between and within Member States. We share the Commission’s view that ambitious EU action can make a difference in reversing the ever-growing number of cancer cases across Europe.

The Erasmus MC Department of Urology welcomes the Europe’s Beating Cancer Plan and fully supports the objectives as laid down in the roadmap. In our daily clinical practice of oncological urology, we face the serious impact of cancer on patients and their relatives, in particular by prostate cancer and bladder cancer.

I would like to see more emphasis given to childhood cancers. Further understanding and safe treatment will enhance children’s lives and that of their families. My son received two indeterminate minimal Residual disease findings early in his treatment which was not changed because his doctors did not know how to interpret these findings. He subsequently relapsed.

Uneven access to preventive measures, treatment and care The arsenal of anticancer therapies is only as good as the deployment of it. In the age where Germany is looking to hire nurses from Mexico, UK has 42,000 nursing and 10,000 medical vacancies– the challenge is how to achieve better access with increasingly scarce resources.Technological Innovation to improve efficiencies, reduce wastage and increase the…

I am surprised to see that one Cancer Plan: Refers to addressing the disease and not to the patient. This is not cancer but the patient with cancer. — There is no plan for medication errors, despite the high risk involved in the medication and the condition of the patient (especially in children with a need for dose adjustments).

Filed in Spanish · English published by the European Commission

The Standing Committee of European Doctors (CPME) welcomes the European Commission roadmap on the Europe’s Beating Cancer Plan and its overall objective to improve the prevention, detection, treatment and management of cancer in the EU while reducing health inequalities between and within the EU member states.

In her opening address on 4th February, President von der Leyen noted that ‘prevention is the best cure we have’. Indeed, the HPV vaccine is the greatest opportunity we have had to prevent cancer in decades, and the roadmap presented by the Beating Cancer Plan is to be commended for its commitment to put prevention at the forefront of actions to tackle cancer in Europe, on the back of the call from the Health at a…

Representing over 25,000 members from over 160 countries, the European Society for Medical Oncology (ESMO) welcomes the consultation on the roadmap paving the way for Europe’s Beating Cancer Plan. ESMO considers the following as priorities within the key pillars, as well as neglected areas we feel must be reflected in the Plan.

EU Cancer Plan should consider policies that encourage the use of vaping products by smokers. In both the UK and France, increases in vaping have been clearly associated with decreases in smoking prevalence. So, both included use of electronic cigarettes in their annual “stop smoking”-campaigns.

The European Academy for Dermatology and Venereology (EADV) is a non-profit organization with 8000 members active in the field of Dermatology-Venereology from all European member states and beyond. The EADV greatly welcomes the initiative of the EU Commissioner on Health and Food Safety, Mrs. S. Kyriakides, to launch an EU-wide debate on Europe´s Beating Cancer Plan.

The European vegetarian movement, represented by its umbrella organisation European Vegetarian Union (EVU), would like to seize upon the present consultation to stress the link between food and diets and health concerns in the European Union.

Taking note of the references in the roadmap to: - The importance of lifestyle choices, including alcohol consumption - The wish to tie into other priorities of the Commission, such as food and nutrition and including the Farm to Fork strategy - Potential instruments such as taxation, including in relation to deterring alcohol abuse - The plan to seek engagement with businesses and industry, The Brewers of Europe…

The EORTC welcomes the roadmap high-level objectives of improving the quality and accessibility of cancer treatments. Collaborative clinical research to maximise impact and knowledge translation into new therapies and clinical practice is a key European bottleneck for access to all. It is central to EORTC contribution here in.

The EIWH welcomes the proposed Europe’s Beating Cancer Plan to support Member States to strengthen policy and programmes at every stage of the disease: prevention, diagnosis, treatment, life as a cancer survivor and palliative care.Large strides have been made to reduce the burden of cancer in Europe through improved screening and treatment.

The Arbeitsgemeinschaft für Berufs- und Umweltdermatologie (ABD) e.V. in the German Dermatological Society (DDG) mainly supports the ‘Health in All Policies’ approach. Only this approach will make it possible to address the immense challenges strategically.

Filed in German · English published by the European Commission

There is a need for collaborative large-scale funded research initiatives focused on difficult to treat rare cancers which represent an urgent unmet clinical need across Europe; e.g. cancers such as glioblastoma (grade IV primary brain tumours) for which there have been no significant advances in patient survival for several decades.

Preventing exposure to carcinogenic hazardous drugs Europe’s Beating Cancer Plan for Europe has to consider the potential benefits for workers, the healthcare system, patients and their families, by what has already identified as a preventive instrument in the roadmap, namely further legislative measures to reduce exposure to carcinogenic substances in the workplace.

When we talk about Patients and survivors who suffer stigma and discrimination, I believe that we cannot ignore in this double sentence' that the public administrations themselves discriminate against us when, despite having been diagnosed and being in treatment for a chronic cancer, they deny us access to disability pensions.

There is a need for collaborative large-scale funded research initiatives focused on difficult to treat rare cancers which represent an urgent unmet clinical need across Europe; eg cancers such as glioblastoma ( grade IV primary brain tumours) for which there have been no significant advances in patient survival for several decades.

The action plan of the European Commission is not only timely, but also much needed. So the Commission should be congratulated. Unfortunately, though, the specific needs of children with cancer are (as usual) not specifically stressed and no/few specific action points are highlighted to address the most common cause of death by disease in children and adolescents in a more effective way.

There is a strong need for collaborative large-scale funded research initiatives focused on difficult to treat rare cancers which represent an urgent unmet clinical need across Europe; eg cancers such as glioblastoma ( grade IV primary brain tumours) for which there have been no significant advances in patient survival for several decades.

Dear Sir and Madam, We would like to alert you regarding several formulations of ENDOXAN (Baxter) sold in France. We identified an increase of severe unexpected side effects and deaths related to some batches. We did question the national government agency regarding related AMM and requested investigations on the traceability and the quality of all the ENDOXAN formulations.

Funding for biomedical research to cancer is adequate in many EU countries. Some might even argue that too much funding is going to biomedical cancer research in comparison to other medical areas with needs (geriatry, psychiatry, ...) . However, fighting cancer in society requires much more than just biomedical research, which is often limited to finding a cure or a drug for patients that suffer from cancer.

EDF, European Dermatology Forum The EDF is the scientific forum of European opinion leaders in Dermatology. As special focus for us is the clinical work, but also the scientific progress in skin cancer prevention and treatment. The clinical burden of this disease is constantly rising and incidence rates for all types of skin cancer are growing year per year all over Europe.

There is an urgent unmet need for collaborative large-scale funded research initiatives focused on difficult to treat rare cancers which represent an urgent unmet clinical need across Europe; eg cancers such as glioblastoma ( grade IV primary brain tumours) for which there have been no significant advances in patient survival for several decades.

Gynecological cancers are important causes of death globally. However, an important fraction of gynecological cancer mortality is preventable by obesity and tobacco control programs, human papillomavirus (HPV) vaccination programs, awareness and training programs for recognizing early signs and symptoms of the disease, and national population-based screening programs.

Therapeutic activity: For a new care model In both the Member States and the European recommendations, the link between the city and the hospital is often very poorly ensured and there is very little coordination between all the actors who can be involved in the care of patients in the context of complementary therapeutic proposals.

Filed in French · English published by the European Commission

I miss a mention (inside the "knowledge" section, maybe) focused on fighting agains fake news in cancer. There are lots of fake med proposals and cuacks trying to convince patients to try their frauds. There are literally thousands of webpages that, never better said, waive a spider web waiting for the patient to be tangled in their persuasive speeches: "Natural", "Chemical-free", "the true cure, not like the…

One of the main drivers of eating habits is one of the following: Ill-informed parents are very damaging to their children’s health by feeding them into their children. Children from such an environment take their habits to adulthood. Example: The slopes of around 90 % of children at school are basically the same: Hog or white makers of white flour and sausage, with added sweetening. Who should change?

Filed in Czech · English published by the European Commission